World Environment Day: Strong Economies Drive Clean Environments
/
Date05 Jun 2019
Email Print Friendly Share Substantial progress has been made on today’s new diesel engines now in operation in the United States and Europe. These new-generation... Read More →
Wintrust Financial Corporation Announces Plans to Acquire STC Capital Bank
/
Date05 Jun 2019
Email Print Friendly Share ROSEMONT, Ill., June 05, 2019 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced the signing of a definitive... Read More →
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
/
Date05 Jun 2019
Email Print Friendly Share TUSTIN, Calif., June 05, 2019 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO)... Read More →
Quest Solution Reports Full Year 2018 Revenue up to $56.2M; Fourth Quarter Gross Margin Improves to 32%
/
Date05 Jun 2019
Email Print Friendly Share Fiscal year 2018 revenue grew 12% excluding impact of ASC 606 Fiscal Year 2018 adjusted EBITDA increased 31% Q4 2018 revenue... Read More →
The Ensign Group Acquires Home Health and Hospice Operations in Wisconsin
/
Date05 Jun 2019
Email Print Friendly Share MISSION VIEJO, Calif., June 05, 2019 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™... Read More →
Dermavant Sciences Announces First Patient Dosed in PSOARING, its Pivotal Phase 3 Clinical Program for Tapinarof for the Topical Treatment of Plaque Psoriasis
/
Date05 Jun 2019
Email Print Friendly Share Top-line data is anticipated in the first half of 2020 If PSOARING trials are successful, a New Drug Application (NDA) filing... Read More →
Hagar hf. – Ársskýrsla 2018/19
/
Date05 Jun 2019
Email Print Friendly Share Ársskýrsla Haga hf. fyrir rekstrarárið 2018/19 hefur verið gefin út. Ársskýrslan er gefin út á rafrænu formi og má finna hana hér... Read More →
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS
/
Date05 Jun 2019
Email Print Friendly Share LA JOLLA, Calif., June 05, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:... Read More →